<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36265904</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2373-2822</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>eNeuro</Title><ISOAbbreviation>eNeuro</ISOAbbreviation></Journal><ArticleTitle>Distribution Features and Potential Effects of Serotonin in the Cerebrum of SOD1 G93A Transgenic Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ENEURO.0001-22.2022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1523/ENEURO.0001-22.2022</ELocationID><Abstract><AbstractText>Serotonin (5-HT) participates in the pathogenesis of amyotrophic lateral sclerosis (ALS), but its effects have not been completely clarified. Therefore, we observed the distribution features and potential effects of 5-HT in the cerebrum of G93A SOD1 transgenic (TG) and wild-type (WT) mice by fluorescence immunohistochemistry, Western blotting, ELISA, as well as motor function measurements. Both 5-HT and tryptophan hydroxylase-2 (TPH2) were mainly present in the limbic systems of the cerebrum, such as the glomerular layer of the olfactory bulb, nucleus accumbens, cingulate, fimbria of the hippocampus, mediodorsal thalamic nucleus, habenular nucleus, ventromedial hypothalamus nucleus, lateral hypothalamus area, dorsal raphe nucleus, and piriform cortex. TPH2 and 5-HT were expressed in cell bodies in the dorsal raphe nucleus and piriform cortex, while in other regions they were distributed as filaments and clump shapes in axons. The TPH2 distribution in the cerebrum of TG was significantly lower than that in WT in preset, onset, and progression stages. TPH2 expression in the fimbria of the hippocampus, mediodorsal thalamic nucleus, habenular nucleus, ventromedial hypothalamus nucleus and lateral hypothalamus area was increased in the onset stage and decreased in the progression stage, gradually decreased in the cingulate with disease progression and significantly decreased in the glomerular layer of the olfactory bulb and nucleus accumbens in the onset stage in TG. The number of mammalian achaete-scute homolog-1 in the subventricular zone (SVZ) in TG was significantly lower than that in WT, which was correlated with the TPH2 distribution. Double immunofluorescence staining showed that TPH2, mammalian achaete-scute homolog-1 and 5-HT were mainly expressed in neurons but rarely expressed in microglia or astrocytes in the piriform cortex. The relative fluorescence density of TPH2 in the cingulate region was negatively correlated with the disease severity. Our findings suggest that 5-HT plays a protective role in ALS, likely by regulating neural stem cells in the subventricular zone that might be involved in neuron development in the piriform cortex.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 He et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Binjun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Life Science, Nanchang University, Nanchang, Jiangxi 330031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenzhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Maoming People's Hospital, Maoming, Guangdong 525000, China xurenshi@ncu.edu.cn hailipan@qq.com xiong715@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Haili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China xurenshi@ncu.edu.cn hailipan@qq.com xiong715@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Life Science, Nanchang University, Nanchang, Jiangxi 330031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0313-3434</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi 330006, China xurenshi@ncu.edu.cn hailipan@qq.com xiong715@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>eNeuro</MedlineTA><NlmUniqueID>101647362</NlmUniqueID><ISSNLinking>2373-2822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>333DO1RDJY</RegistryNumber><NameOfSubstance UI="D012701">Serotonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054022" MajorTopicYN="Y">Cerebrum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-HT</Keyword><Keyword MajorTopicYN="N">Mash1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neural stem cell</Keyword><Keyword MajorTopicYN="N">subventricular zone</Keyword><Keyword MajorTopicYN="N">tryptophan hydroxylase 2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36265904</ArticleId><ArticleId IdType="pmc">PMC9651208</ArticleId><ArticleId IdType="doi">10.1523/ENEURO.0001-22.2022</ArticleId><ArticleId IdType="pii">ENEURO.0001-22.2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R, Boy&#xe9; P, Vilianovitch L, Sohr R, Tenner K, H&#xf6;rtnagl H, Bader M (2009) Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U&#x2009;S&#x2009;A 106:10332&#x2013;10337. 10.1073/pnas.0810793106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810793106</ArticleId><ArticleId IdType="pmc">PMC2700938</ArticleId><ArticleId IdType="pubmed">19520831</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, Govaarts R, Pijnenburg YAL, de Haan RJ, de Visser M, Schmand BA (2018) The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:995&#x2013;1002. 10.1136/jnnp-2017-317459</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317459</ArticleId><ArticleId IdType="pubmed">29439163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertel O, Malessa S, Sluga E, Hornykiewicz O (1991) Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Res 566:54&#x2013;60. 10.1016/0006-8993(91)91680-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(91)91680-y</ArticleId><ArticleId IdType="pubmed">1726065</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkowski LF, Craig TA, Stricklin OE, Johnson KA, Nichols NL (2020) 5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A). Respir Physiol Neurobiol 279:103471. 10.1016/j.resp.2020.103471</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103471</ArticleId><ArticleId IdType="pmc">PMC7384973</ArticleId><ArticleId IdType="pubmed">32504811</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y, Kwong L, Lee EB, Elman L, McCluskey L, Fang L, Feldengut S, Ludolph AC, Lee VM, Braak H, Trojanowski JQ (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20&#x2013;38. 10.1002/ana.23937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A, Heath PR, Holden H, Kasher P, Bender FLP, Claes F, Lambrechts D, Sendtner M, Carmeliet P, Shaw PJ (2010) Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis. BMC Genomics 11:203. 10.1186/1471-2164-11-203</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-11-203</ArticleId><ArticleId IdType="pmc">PMC2861063</ArticleId><ArticleId IdType="pubmed">20346106</ArticleId></ArticleIdList></Reference><Reference><Citation>Brylev L, Ataulina A, Fominykh V, Parshikov V, Vorobyeva A, Istomina E, Shikhirimov R, Salikov A, Zakharova M, Guekht A, Beghi E (2020) The epidemiology of amyotrophic lateral sclerosis in Moscow (Russia). Amyotroph Lateral Scler Frontotemporal Degener 21:410&#x2013;415. 10.1080/21678421.2020.1752252</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1752252</ArticleId><ArticleId IdType="pubmed">32476476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenn A, Walsh CA (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365&#x2013;369. 10.1126/science.1074192</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1074192</ArticleId><ArticleId IdType="pubmed">12130776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41:118&#x2013;130. 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, Giannini F, Mandrioli J, Mora G, Sabatelli M; ITALSGEN Consortium, Ajmone C, Mastro E, Pain D, Mandich P, Penco S, Restagno G, Zollino M, Surbone A (2014) Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry 85:478&#x2013;485. 10.1136/jnnp-2013-305546</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Lauria G (2017) Pain in amyotrophic lateral sclerosis. Lancet Neurol 16:144&#x2013;157. 10.1016/S1474-4422(16)30358-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30358-1</ArticleId><ArticleId IdType="pubmed">27964824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciranna L (2006) Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol 4:101&#x2013;114. 10.2174/157015906776359540</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015906776359540</ArticleId><ArticleId IdType="pmc">PMC2430669</ArticleId><ArticleId IdType="pubmed">18615128</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Johnson BS, King OD, Gitler AD, Shorter J (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123:1191&#x2013;1201. 10.1242/jcs.051672</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.051672</ArticleId><ArticleId IdType="pmc">PMC2848109</ArticleId><ArticleId IdType="pubmed">20356930</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufr&#xe8;re B, Couratier P (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74:328&#x2013;334. 10.1093/ajcn/74.3.328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Spreux-Varoquaux O, Bensimon G, Jullien P, Lacomblez L, Salachas F, Bruneteau G, Pradat P-F, Loeffler J-P, Meininger V (2010) Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PLoS One 5:e13346. 10.1371/journal.pone.0013346</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013346</ArticleId><ArticleId IdType="pmc">PMC2954194</ArticleId><ArticleId IdType="pubmed">20967129</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H, Scekic-Zahirovic J, Vercruysse P, Marques C, Dirrig-Grosch S, Dieterl&#xe9; S, Picchiarelli G, Sinniger J, Rouaux C, Dupuis L (2017) Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis. Ann Neurol 82:444&#x2013;456. 10.1002/ana.25030</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25030</ArticleId><ArticleId IdType="pubmed">28856708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7:616&#x2013;630. 10.1038/nrneurol.2011.152</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Filip M, Bader M (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep 61:761&#x2013;777. 10.1016/S1734-1140(09)70132-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1734-1140(09)70132-X</ArticleId><ArticleId IdType="pubmed">19903999</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport J-C, Sturtz F, Camu W, Couratier P (2009) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:113&#x2013;117. 10.1080/17482960802295192</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleichman AJ, Carmichael ST (2014) Astrocytic therapies for neuronal repair in stroke. Neurosci Lett 565:47&#x2013;52. 10.1016/j.neulet.2013.10.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.10.055</ArticleId><ArticleId IdType="pubmed">24184876</ArticleId></ArticleIdList></Reference><Reference><Citation>Green AR (2006) Neuropharmacology of 5-hydroxytryptamine. Br J Pharmacol 147 [Suppl 1]:S145&#x2013;S152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1760750</ArticleId><ArticleId IdType="pubmed">16402098</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemot F, Joyner AL (1993) Dynamic expression of the murine Achaete-Scute homologue Mash-1 in the developing nervous system. Mech Dev 42:171&#x2013;185. 10.1016/0925-4773(93)90006-j</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0925-4773(93)90006-j</ArticleId><ArticleId IdType="pubmed">8217843</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL (1993) Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75:463&#x2013;476. 10.1016/0092-8674(93)90381-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90381-y</ArticleId><ArticleId IdType="pubmed">8221886</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R, Richter N, Sauerbier A, Chaudhuri KR, Martinez-Martin P, Storch A, Hermann A (2016) Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol 7:117. 10.3389/fneur.2016.00117</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00117</ArticleId><ArticleId IdType="pmc">PMC4958907</ArticleId><ArticleId IdType="pubmed">27504105</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772&#x2013;1775. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada M, Yoshikawa H, Ueda Y, Kurokawa MS, Watanabe K, Sakakibara M, Tadokoro M, Akashi K, Aoki H, Suzuki N (2006) Introduction of the MASH1 gene into mouse embryonic stem cells leads to differentiation of motoneuron precursors lacking Nogo receptor expression that can be applicable for transplantation to spinal cord injury. Neurobiol Dis 22:509&#x2013;522. 10.1016/j.nbd.2005.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.12.020</ArticleId><ArticleId IdType="pubmed">16497507</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney MM, Sinnott J, Osman KL, Deninger I, Andel E, Caywood V, Mok A, Ballenger B, Cummings K, Thombs L, Lever TE (2019) Mice lacking brain-derived serotonin have altered swallowing function. Otolaryngol Head Neck Surg 161:468&#x2013;471. 10.1177/0194599819846109</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599819846109</ArticleId><ArticleId IdType="pmc">PMC8341204</ArticleId><ArticleId IdType="pubmed">31035861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Schneider A (2010) Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS One 5:e15445. 10.1371/journal.pone.0015445</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015445</ArticleId><ArticleId IdType="pmc">PMC2978730</ArticleId><ArticleId IdType="pubmed">21102999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilaire G, Voituron N, Menuet C, Ichiyama RM, Subramanian HH, Dutschmann M (2010) The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol 174:76&#x2013;88. 10.1016/j.resp.2010.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2010.08.017</ArticleId><ArticleId IdType="pmc">PMC2993113</ArticleId><ArticleId IdType="pubmed">20801236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges MR, Richerson GB (2010) The role of medullary serotonin (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation. J Appl Physiol (1985) 108:1425&#x2013;1432. 10.1152/japplphysiol.01270.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.01270.2009</ArticleId><ArticleId IdType="pmc">PMC2867541</ArticleId><ArticleId IdType="pubmed">20133432</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165&#x2013;229. 10.1152/physrev.1992.72.1.165</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1992.72.1.165</ArticleId><ArticleId IdType="pubmed">1731370</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Thau N, Dengler R, Petri S (2010) Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res 213:82&#x2013;87. 10.1016/j.bbr.2010.04.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.04.042</ArticleId><ArticleId IdType="pubmed">20450936</ArticleId></ArticleIdList></Reference><Reference><Citation>Koschnitzky JE, Quinlan KA, Lukas TJ, Kajtaz E, Kocevar EJ, Mayers WF, Siddique T, Heckman CJ (2014) Effect of fluoxetine on disease progression in a mouse model of ALS. J Neurophysiol 111:2164&#x2013;2176. 10.1152/jn.00425.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00425.2013</ArticleId><ArticleId IdType="pmc">PMC4097867</ArticleId><ArticleId IdType="pubmed">24598527</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lu Y, Liang H, Tang C, Zhu L, Zhang J, Xu R (2016) Changes in the expression of FUS/TLS in spinal cords of SOD1 G93A transgenic mice and correlation with motor-neuron degeneration. Int J Biol Sci 12:1181&#x2013;1190. 10.7150/ijbs.16158</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.16158</ArticleId><ArticleId IdType="pmc">PMC5069440</ArticleId><ArticleId IdType="pubmed">27766033</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Wu C, Deng Y, Zhu L, Zhang J, Gan W, Tang C, Xu R (2017) Aldehyde dehydrogenases 1A2 expression and distribution are potentially associated with neuron death in spinal cord of Tg(SOD1*G93A)1Gur mice. Int J Biol Sci 13:574&#x2013;587. 10.7150/ijbs.19150</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.19150</ArticleId><ArticleId IdType="pmc">PMC5441175</ArticleId><ArticleId IdType="pubmed">28539831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Tang C, Zhu L, Li J, Liang H, Zhang J, Xu R (2016) The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Int J Biol Sci 12:1140&#x2013;1149. 10.7150/ijbs.15938</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15938</ArticleId><ArticleId IdType="pmc">PMC4997058</ArticleId><ArticleId IdType="pubmed">27570488</ArticleId></ArticleIdList></Reference><Reference><Citation>McCluskey L, Vandriel S, Elman L, Van Deerlin VM, Powers J, Boller A, Wood EM, Woo J, McMillan CT, Rascovsky K, Grossman M (2014) ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci 345:118&#x2013;124. 10.1016/j.jns.2014.07.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.022</ArticleId><ArticleId IdType="pmc">PMC4177937</ArticleId><ArticleId IdType="pubmed">25086858</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L, Barri&#xe8;re G, De Deurwaerd&#xe8;re P, Cazalets J-R, Bertrand SS (2014) Monoaminergic control of spinal locomotor networks in SOD1G93A newborn mice. Front Neural Circuits 8:77. 10.3389/fncir.2014.00077</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2014.00077</ArticleId><ArticleId IdType="pmc">PMC4081764</ArticleId><ArticleId IdType="pubmed">25071458</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki I, Asanuma M (2016) Serotonin 1A receptors on astrocytes as a potential target for the treatment of Parkinson&#x2019;s disease. Curr Med Chem 23:686&#x2013;700. 10.2174/0929867323666160122115057</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666160122115057</ArticleId><ArticleId IdType="pmc">PMC4997990</ArticleId><ArticleId IdType="pubmed">26795196</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Brunaud-Danel V, Dallongeville J, Duhamel A, Laurier-Grymonprez L, de Reuck J, Wiart AC, Perez T, Richard F, Amouyel P, Bordet R, Defebvre L, Dest&#xe9;e A, Devos D (2012) Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:194&#x2013;201. 10.3109/17482968.2011.610110</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.610110</ArticleId><ArticleId IdType="pubmed">21913867</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 169:22&#x2013;25. 10.1016/s0022-510x(99)00211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00211-7</ArticleId><ArticleId IdType="pubmed">10540003</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C, Mitrecic D, Falnikar A, Lepore AC (2015) Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells 7:380&#x2013;398. 10.4252/wjsc.v7.i2.380</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v7.i2.380</ArticleId><ArticleId IdType="pmc">PMC4369494</ArticleId><ArticleId IdType="pubmed">25815122</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfc;bling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS (2014) Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:174&#x2013;179. 10.3109/21678421.2013.868001</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType="pubmed">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, Calvo AC, Rando A, Mu&#xf1;oz MJ, Zaragoza P, Osta R (2015) Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp Anim 64:147&#x2013;153. 10.1538/expanim.14-0077</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.14-0077</ArticleId><ArticleId IdType="pmc">PMC4427729</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado LGR, Bicalho ICS, Vidigal-Lopes M, Prado VGR, Gomez RS, de Souza LC, Teixeira AL (2017) Depression and anxiety in a case series of amyotrophic lateral sclerosis: frequency and association with clinical features. Einstein (Sao Paulo) 15:58&#x2013;60. 10.1590/S1679-45082017AO3870</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1679-45082017AO3870</ArticleId><ArticleId IdType="pmc">PMC5433308</ArticleId><ArticleId IdType="pubmed">28444090</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12:25. 10.3389/fnmol.2019.00025</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ptak K, Yamanishi T, Aungst J, Milescu LS, Zhang R, Richerson GB, Smith JC (2009) Raph&#xe9; neurons stimulate respiratory circuit activity by multiple mechanisms via endogenously released serotonin and substance P. J Neurosci 29:3720&#x2013;3737. 10.1523/JNEUROSCI.5271-08.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5271-08.2009</ArticleId><ArticleId IdType="pmc">PMC2940110</ArticleId><ArticleId IdType="pubmed">19321769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandyk R (2006) Serotonergic mechanisms in amyotrophic lateral sclerosis. Int J Neurosci 116:775&#x2013;826. 10.1080/00207450600754087</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207450600754087</ArticleId><ArticleId IdType="pubmed">16861147</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G, Siciliano M, Trojano L, Femiano C, Monsurr&#xf2; MR, Tedeschi G, Trojsi F (2017) Apathy in amyotrophic lateral sclerosis: insights from dimensional apathy scale. Amyotroph Lateral Scler Frontotemporal Degener 18:434&#x2013;442. 10.1080/21678421.2017.1313865</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313865</ArticleId><ArticleId IdType="pubmed">28431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki L, Coulon P, Sabel-Goedknegt EH, Ruigrok TJH (2012) Organization of cerebral projections to identified cerebellar zones in the posterior cerebellum of the rat. J Neurosci 32:10854&#x2013;10869. 10.1523/JNEUROSCI.0857-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0857-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621006</ArticleId><ArticleId IdType="pubmed">22875920</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, Leigh PN, Goldstein LH (2013) Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 84:494&#x2013;498. 10.1136/jnnp-2012-303526</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303526</ArticleId><ArticleId IdType="pubmed">23033353</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Landers JE (2010) RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 11:275&#x2013;290. 10.1007/s10048-010-0239-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-010-0239-4</ArticleId><ArticleId IdType="pubmed">20349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, Yang WS, Kalb R, Galasko DR, Montine TJ, Trojanowski JQ (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 7:409&#x2013;416. 10.1016/S1474-4422(08)70071-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren Y, Janssens J, Van Dam D, De Deyn PP (2018) Serotonergic dysfunction in amyotrophic lateral sclerosis and Parkinson&#x2019;s disease: similar mechanisms, dissimilar outcomes. Front Neurosci 12:185. 10.3389/fnins.2018.00185</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00185</ArticleId><ArticleId IdType="pmc">PMC5869258</ArticleId><ArticleId IdType="pubmed">29615862</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther DJ, Bader M (2003) A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66:1673&#x2013;1680. 10.1016/s0006-2952(03)00556-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-2952(03)00556-2</ArticleId><ArticleId IdType="pubmed">14563478</ArticleId></ArticleIdList></Reference><Reference><Citation>Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, Mosnik D, Appel SH, Schulz PE (2010) Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol 17:103&#x2013;110. 10.1111/j.1468-1331.2009.02801.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02801.x</ArticleId><ArticleId IdType="pubmed">19874396</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gingrich JA, Guo XE, Tecott LH, Mann JJ, Hen R, Horvath TL, Karsenty G (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976&#x2013;989. 10.1016/j.cell.2009.06.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.06.051</ArticleId><ArticleId IdType="pmc">PMC2768582</ArticleId><ArticleId IdType="pubmed">19737523</ArticleId></ArticleIdList></Reference><Reference><Citation>Young SN (2007) How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci 32:394&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077351</ArticleId><ArticleId IdType="pubmed">18043762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Lu Y, Fang X, Zhang J, Li J, Li S, Deng X, Yu Y, Xu R (2015) An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis&#x2019;s disease-like transgenic (G93A SOD1) mice. Neurodegener Dis 15:1&#x2013;12. 10.1159/000369466</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369466</ArticleId><ArticleId IdType="pubmed">25591625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Liu Y, Yang F, Chen W, Jiang J, He P, Jiang S, Li M, Xu R (2020) All-trans retinoic acid exerts neuroprotective effects in amyotrophic lateral sclerosis-like Tg (SOD1*G93A)1Gur mice. Mol Neurobiol 57:3603&#x2013;3615. 10.1007/s12035-020-01973-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-01973-8</ArticleId><ArticleId IdType="pubmed">32548665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>